Veritas Investment Management (UK)’s Champions Oncology CSBR Stock Holding History

Veritas Investment Management (UK)’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,083	Closed	-$15K	–	33
2020 Q1	$15K	Hold	2,083	–	–	﹤0.01%	32
2019 Q4	$17K	Hold	2,083	–	–	﹤0.01%	33
2019 Q3	$12K	Hold	2,083	–	–	﹤0.01%	31
2019 Q2	$16K	Hold	2,083	–	–	﹤0.01%	32
2019 Q1	$20K	Hold	2,083	–	–	0.01%	31
2018 Q4	$16K	Hold	2,083	–	–	0.01%	29
2018 Q3	$36K	Hold	2,083	–	–	0.01%	29
2018 Q2	$13K	Hold	2,083	–	–	﹤0.01%	30
2018 Q1	$8K	Hold	2,083	–	–	﹤0.01%	36
2017 Q4	$8K	Hold	2,083	–	–	﹤0.01%	40
2017 Q3	$8K	Hold	2,083	–	–	﹤0.01%	47
2017 Q2	$5K	Hold	2,083	–	–	﹤0.01%	44
2017 Q1	$7K	Buy	+2,083	New	+$7.29K	﹤0.01%	46

Other funds holding CSBR

BPI

Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OMC

Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

Veritas Investment Management (UK)'s CSBR Position: Q2 2020 in Review

Veritas Investment Management (UK) sold out of Champions Oncology (CSBR) in Q2 2020, closing a stake of 2,083 shares — an estimated $15K sold.

Veritas Investment Management (UK) first reported a position in CSBR in Q1 2017 and held it in 13 quarters. The position peaked at $36K in Q3 2018. 44 funds tracked by Wall St. Rank hold CSBR as of Q2 2020.

Veritas Investment Management (UK) reported no remaining Champions Oncology position as of Q2 2020 after selling out during the quarter.
Veritas Investment Management (UK) sold 2,083 Champions Oncology shares in Q2 2020, an estimated $15K.
Veritas Investment Management (UK) first reported a position in Champions Oncology in Q1 2017 and held it in 13 quarters.
Veritas Investment Management (UK)'s Champions Oncology position peaked at $36K in Q3 2018.
44 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2020.

Based on Veritas Investment Management (UK)'s 13F filing for Q2 2020, filed 6 Aug 2020.